Livzon Pharmaceutical Group Inc. is a comprehensive pharmaceutical enterprise integrating development & research, production and sales of pharmaceutical products. Livzon has 9 GMP production plants located in Guangdong, Shanghai, Sichuan, Fujian, 3 plantation bases for Chinese drug preparation production located in Shanxi, Gansu, Yunan of China, with more than 5,700 employees. Livzon has modern industrial chain and product group, operates to manufacture drug preparation, bulk medicines and intermediates, as well as diagnostic reagents and equipment, with approximate 280 products therapeutically grouped as gastrointestinal, cardio-cerebral-vascular, anti-biotic, gonadotropic hormone etc. Meanwhile, Livzon possesses production bases as leading manufacturer of Chinese drug preparation injection, and specialist bulk medicines and intermediates such as fermented antibiotics, sterile cephalosporins, and hypolipidemic “statins”.

Fujisawa Pharmaceutical Co. Ltd. develops, manufactures and markets pharmaceuticals and medical products. The Group's principal activity is the manufacture and sale of pharmaceuticals, medical equipment and supplies, home care products, chemicals and animal health products. Pharmaceuticals (ethical drugs, OTC drugs, toilet goods) accounted for 91% of fiscal 2002 revenues and other operations (food additives, industrial chemicals, animal drugs, research and clinical reagents). It was founded in 1894 and was headquartered in Osaka, JP

Sandoz AG, part of Novartis AG, is a company headquartered in Basel, Switzerland, that develops generic medicines and biosimilars.

Western Research, a subsidiary of AMETEK, Inc., is a company headquartered in Canada that manufactures gas analysis instrumentation and air emissions monitoring equipment. It was acquired by AMETEK, Inc. from Orbus Pharma, Inc. on April 30, 1998 for $13.54 million.

Medical Vision Technology provides medical-grade miniature endoscopes. They provide medical devices to solve unmet clinical needs through integrating academic resources, R&D capabilities, and industry resources. Their products include UGI monitoring system, inspection scope, and NG tude placement image-assisting system. They also provide upper gastrointestinal bleeding detection system.

Part of MED Alliance Solutions LLC, Enterix Pty Ltd. is a company headquartered in North Ryde, Australia. The firm manufactures and distributes screening tests equipment for colorectal cancer.

Pyramid AG engages in the design and manufacture of individualized hardware solutions for optoelectronics, cybersecurity, medical and technical engineering, sensor technology, banking, retail, hospitality, healthcare, transportation, and entertainment industries. It offers products under the brands of Polytouch, which has interactive kiosk solutions for self-service automation; Akhet, a tailor-made IPC's and servers; and faytech, a touch screen monitors and PC's. The company was founded by Claus-Georg Müller on May 8, 2006 and is headquartered in Munich, Germany.

Regents of The University of Michigan provides administers bonds on behalf of the University. The company is headquartered in Ann Arbor, MI.

Shandong Dongda High-tech Huatai Pharmaceutical Co., Ltd., established on 1992-07-23, Business scope includes production,Sales:Freeze-dried powder injection,small volume injection,API(The validity period is subject to the license),food,Healthy food;Biotechnology R&D;Import and export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Intact Therapeutics, Inc. manufactures gels for local drug delivery for gastrointestinal diseases. The company is headquartered in Belmont, CA.

Yunnan Phytopharmaceutical Co. Ltd., part of Meilleure Health International Industry Group Ltd., is a company headquartered in Kunming, China, involved in pharmaceutical preparations. On October 11, 2004 Meilleure Health International Industry Group Ltd. acquired Yunnan Phytopharmaceutical Co. Ltd. from New World Liberty China Ventures Ltd.

Nanjing Bode Biopharmaceutical Co., Ltd, established on 2003-03-10, The business scope includes raw materials and various dosage forms(including but not limited to tablets,Capsules,aerosol,immune preparations,Granules,ointment,pill,oral liquid,inhalant,injection,Liniment,tincture,suppositories)pharmaceutical products(Including but not limited to chemical raw materials,Chemicals,Chinese herbal medicine,Chinese patent medicine,Chinese Herbal Medicine,biochemical drug,Biological product,Narcotic Drugs,Psychotropic drugs,toxic drugs for medical use[Compatible with business scope],vaccine),Health products,Research and development of medical devices and related products,manufacturing and sales;Chinese patent medicine,Chemical API,Chemicals,Antibiotic API,antibiotic preparation,Wholesale of biochemical drugs.Technology development of pharmaceuticals and medical devices,transfer,consult;business management,Financial Management Consulting;Own house rental;real estate development,Sales and Property Management;Self-operated and agent import and export business of various commodities and technologies.(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Ironwood Pharmaceuticals, Inc is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.. Microbia was founded by postdocs from the lab of Gerald Fink at the Whitehead Institute to commercialize approaches that had been developed in the lab to improve industrial fermentation of fungi, to genetically engineer them to produce secondary metabolites more efficiently or to produce new ones as leads for drug discovery or as products for use in industry, and to identify drug targets in fungi for antifungal drug discovery. In 2002 the company hired John Talley to lead their antifungal drug discovery efforts, which at the time were focused on identifying small molecules that could inhibit fungal invasins, along with Mark Currie who had also worked at Searle division of Monsanto with Talley, and then had gone to Sepracor, and also Richard Bailey, who had run Monsanto's nutritional business. Currie directed the efforts that led to the discovery of linaclotide, which was based on an enterotoxin produced by some strains of Escherichia coli that cause traveler’s diarrhea.

Ningbo Senguo Pharmaceutical Technology Co., Ltd., established on 2018-07-27, Business scope includes medical technology,Biotechnology,Research and development of product quality inspection technology,technical consulting,Technical Services,technology transfer;Pharmaceutical Intermediates,biological reagent(In addition to drugs),laboratory reagent(Removal of hazardous chemicals and precursor chemicals),chemical reagent(Removal of hazardous chemicals and precursor chemicals),Research and development of Class I medical devices,Sales;Self-operated or agent import and export business of various goods and technologies,Except for goods and technologies that are restricted or prohibited from being imported or exported by the state.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Guizhou Provincial People's Hospital is a private company headquartered in Guiyang, China, that provides medical services.

Wuhan Center Hospital is a Chinese private company located in Wuhan that engages in providing general medical and surgical services and other hospital services.

Yichang Baiji Biotechnology Co., Ltd., established on 2017-03-14, The business scope includes research and development and production of hemostatic materials and related medical consumables(The above business scope shall be operated according to the content verified in the license or approval document;Those who have not obtained relevant valid permits or approval documents,Not allowed to operate);No. I,II,Research and development of Class III medical devices,Production,Sales and related technical consulting services;Medical Technology Development,technology transfer,Technical Services,technical consulting;Planting of Chinese herbal medicines,buy,Sales;cosmetic,R & D and sales of daily chemical products;Import and export business(law,Except for import and export items prohibited or restricted by administrative regulations and designated operations).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Guiqian International Hospital Management Co., Ltd., established on 2016-05-19, Business scope includes legal,regulations,Those prohibited by the State Council's decision shall not operate;law,regulations,The State Council has decided to allow(approval)of,After approval by the examination and approval authority(approval)file management;law,regulations,The State Council has decided that a license is not required(approval)of,Market entities independently choose to operate.(food sales;Pharmaceutical business;sell hygiene products;internal medicine,Gynecology,surgery,obstetrics,Women's Health,Confinement Nursing Center,Pediatrics,Children's Health,Neonatology,Dentistry,Preventive health care,Critical Care Medicine,Emergency Medicine,Anesthesiology,Medical Laboratory,medical imaging,Chinese Medicine;Baby Care Services;Parking lot management service;Health food sales,Sales of formula food for special medical purposes;Sales of infant formula milk powder;Sales of other infant formula food.Involved in licensing projects,It should be operated after obtaining the permission of the relevant department)